NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society. NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand. NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation. NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
Show more
London, GB
Size (employees)
23 (est)
Netscientific is headquartered in London, GB
Report incorrect company information

Netscientific Office Locations

Netscientific has an office in London
London, GB (HQ)
30 Saint Mary Axe - Swiss Re 30 St Mary Axe
Show all (1)
Report incorrect company information

Netscientific Financials and Metrics

Netscientific Financials

Netscientific's revenue was reported to be £518 k in FY, 2016 which is a 559.2% increase from the previous period.

Revenue (FY, 2016)

518 k

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

263 k

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(12.4 m)

EBITDA (FY, 2016)

(12.3 m)

EBIT (FY, 2016)

(12.4 m)

Market capitalization (31-Oct-2017)

28.6 m

Closing share price (31-Oct-2017)


Cash (31-Dec-2016)

9.5 m
Netscientific's current market capitalization is £28.6 m.
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


16 k177.7 k21 k518 k

Revenue growth, %


Cost of goods sold

6 k255 k

Gross profit

15 k263 k
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016


410.8 k25.5 m16.9 m23.2 m9.5 m

Accounts Receivable

260 57.3 k37 k80 k

Current Assets

632.4 k25.9 m17.7 m23.8 m11 m


11.7 k67.1 k348.2 k285 k779 k
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(1.5 m)(4.3 m)(6.2 m)(10.4 m)(12.4 m)

Cash From Operating Activities

(1.2 m)(3.7 m)(6.6 m)(10.6 m)(12.8 m)

Cash From Financing Activities

861.5 k28.9 m190 k17.2 m70 k

Net Change in Cash

(393.3 k)25.1 m(8.8 m)6.2 m(14.4 m)
GBPY, 2016

Financial Leverage

1.1 x
Show all financial metrics
Report incorrect company information